A detailed history of Novak & Powell Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Novak & Powell Financial Services, Inc. holds 2,799 shares of AMGN stock, worth $761,635. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,799
Previous 2,868 2.41%
Holding current value
$761,635
Previous $896 Million 0.66%
% of portfolio
0.52%
Previous 0.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $21,347 - $23,279
-69 Reduced 2.41%
2,799 $902 Million
Q2 2024

Aug 15, 2024

BUY
$262.75 - $319.31 $2,364 - $2,873
9 Added 0.31%
2,868 $896 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $19,358 - $23,368
72 Added 2.58%
2,859 $813 Million
Q4 2023

Feb 21, 2024

BUY
$255.7 - $288.46 $712,635 - $803,938
2,787 New
2,787 $803 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Novak & Powell Financial Services, Inc. Portfolio

Follow Novak & Powell Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novak & Powell Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Novak & Powell Financial Services, Inc. with notifications on news.